INSM · INSMED Inc
$99.02
+0.27 (+0.27%)
At close · Aug 5
Market Cap
$21.46B
Shares
216.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $14,467,393 |
| Martina Flammer | Chief Medical Officer | $4,716,513 |
| Roger Adsett | COO | $4,691,405 |
| Sara Bonstein | CFO | $4,617,429 |
| Michael Smith | Chief Legal Officer | $4,138,160 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $10,943,571 |
| Roger Adsett | COO | $4,256,400 |
| Martina Flammer | Chief Medical Officer | $4,114,856 |
| Drayton Wise | Chief Commercial Officer | $4,109,733 |
| Sara Bonstein | CFO | $4,012,005 |
| Michael Smith | Chief Legal Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $10,411,260 |
| Sara Bonstein | CFO | $4,559,582 |
| Martina Flammer | Chief Medical Officer | $4,221,530 |
| Roger Adsett | COO | $4,007,775 |
| Drayton Wise | Chief Commercial Officer | $3,891,102 |
| Michael Smith | Chief Legal Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $7,789,898 |
| Roger Adsett | COO | $4,643,395 |
| Drayton Wise | Chief Commercial Officer | $4,018,114 |
| Martina Flammer | Chief Medical Officer | $3,762,690 |
| Sara Bonstein | CFO | $3,433,248 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $7,322,642 |
| Chief Operating | Officer | $3,870,935 |
| Sara Bonstein | CFO | $3,452,077 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $6,185,704 |
| Martina Flammer | Chief Medical Officer | $3,934,370 |
| Chief Operating | Officer | $3,293,946 |
| Roger Adsett | COO | $3,293,946 |
| Christine Pellizzari | Director | $3,232,896 |
| Sara Bonstein | CFO | $2,721,791 |
| John Goll | Former Principal Financial Officer | $1,013,377 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $7,175,094 |
| Roger Adsett | COO | $3,728,403 |
| Christine Pellizzari | Director | $2,709,564 |
| S. Nicole Schaeffer | Chief People Strategy Officer | $2,312,597 |
| Paolo Tombesi | CFO | $1,527,332 |
| John Goll | Former Principal Financial Officer | $832,283 |
| Martina Flammer | Chief Medical Officer | $80,185 |
| Sara Bonstein | CFO | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $5,943,159 |
| Roger Adsett | COO | $2,673,150 |
| Christine Pellizzari | Director | $2,030,589 |
| Paolo Tombesi | CFO | $2,023,828 |
| S. Nicole Schaeffer | Chief People Strategy Officer | $1,934,848 |
| John Goll | Former Principal Financial Officer | $763,632 |
| Sara Bonstein | CFO | — |
| Martina Flammer | Chief Medical Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| William Lewis | CEO | $4,352,433 |
| Roger Adsett | COO | $2,338,765 |
| Christine Pellizzari | Director | $1,977,865 |
| Paolo Tombesi | CFO | $1,883,283 |
| S. Nicole Schaeffer | Chief People Strategy Officer | $1,805,402 |
| John Goll | Former Principal Financial Officer | $842,148 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| William H. Lewis | Class I Director | Appointed | 2025-05-16 |
| Leo Lee | Class I Director | Appointed | 2025-05-16 |
| J. Drayton Wise | Chief Commercial Officer | Resigned | 2025-04-17 |
| Carol A. Schafer | Class III director | Appointed | 2024-05-13 |
| Melvin Sharoky, M.D. | Class III director | Appointed | 2024-05-13 |
| Leo Lee | Class III director | Appointed | 2024-05-13 |
| David R. Brennan | Class III director | Appointed | 2024-05-13 |
Key facts
CIK
1104506
CUSIP
457669307
13F (30d)
229 filings
225 filers
Visit website
Investor relations